The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not cause suicidal behaviour. Pfizer's twice-a-day tablet has carried the FDA strongest warning label, known as a black box, since 2009 because of reports of suicidality, hostility and depression.